SCHEMBL7697278

SCHEMBL7697278

O=C(N[C@@H](Cc1ccccc1)C(=O)CNS(=O)(=O)c1ccccc1)c1ccccc1C=Cc1ccc(CN2CCCCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 11/20 0.47
CTSB P07858 5/20 0.47
CTSS P25774 2/20 0.46
CTSK P43235 2/20 0.46
CTSL P07711 2/20 0.44
HRH3 Q9Y5N1 1/20 0.41
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7691261 0.99 CAPN1 (0.47) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7690714 0.91 CAPN1 (0.49) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7696044 0.90 CAPN1 (0.50) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697381 0.89 CAPN1 (0.50) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7690197 0.88 CAPN1 (0.51) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7689922 0.87 CAPN1 (0.57) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7688914 0.86 CAPN1 (0.49) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7696627 0.86 CAPN1 (0.51) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697236 0.86 CAPN1 (0.51) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7693032 0.85 CAPN1 (0.49) CAPN1CTSBCTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed